2024
Rheumatoid arthritis and peripartum cardiovascular complications: focusing on non-traditional cardiovascular risk factors to improve maternal outcomes
Goldstein S, Lindley K. Rheumatoid arthritis and peripartum cardiovascular complications: focusing on non-traditional cardiovascular risk factors to improve maternal outcomes. European Heart Journal 2024, 45: 1537-1539. PMID: 38713839, DOI: 10.1093/eurheartj/ehae164.Peer-Reviewed Original ResearchConceptsCardiovascular risk factorsMaternal cardiovascular risk factorsPre-conception counsellingNon-traditional cardiovascular risk factorsCardio-obstetricsAdverse pregnancy outcomesRisk factorsPregnancy outcomesCardiovascular adverse outcomesAdverse outcomesMaternal outcomesRheumatoid arthritisMaternal cardiovascular complicationsCardiovascular complicationsCounselingOutcomesPregnancyRiskArthritisPracticeFactors426 Brain natriuretic peptide testing and severe maternal morbidity in pregnancies affected by heart disease
Denoble A, Federspiel J, Goldstein S, Culhane J, Dysart K. 426 Brain natriuretic peptide testing and severe maternal morbidity in pregnancies affected by heart disease. American Journal Of Obstetrics And Gynecology 2024, 230: s235-s236. DOI: 10.1016/j.ajog.2023.11.452.Peer-Reviewed Original Research
2023
Antihypertensives in Pregnancy
Denoble A, Goldstein S, Pettker C. Antihypertensives in Pregnancy. Obstetrics And Gynecology Clinics Of North America 2023, 50: 39-78. PMID: 36822710, DOI: 10.1016/j.ogc.2022.10.008.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsSignificant maternal morbidityTreatment of hypertensionAmniotic fluid volumeHypertensive disordersMaternal morbidityPregnant patientsFetal growthCurrent guidelinesEfficacy dataAvailable safetyPregnancyAntihypertensivesFluid volumeClose supervisionHypertensionMorbidityPatientsPostpartumMortalityAvailable dataDiagnosis
2021
734 Severe maternal morbidity by modified WHO classification in women with cardiac disease in pregnancy
DeNoble A, Federspiel J, Wein L, Goldstein S, Grotegut C. 734 Severe maternal morbidity by modified WHO classification in women with cardiac disease in pregnancy. American Journal Of Obstetrics And Gynecology 2021, 224: s460-s461. DOI: 10.1016/j.ajog.2020.12.757.Peer-Reviewed Original Research
2017
Congenital and Acquired Valvular Heart Disease in Pregnancy
Goldstein S, Ward C. Congenital and Acquired Valvular Heart Disease in Pregnancy. Current Cardiology Reports 2017, 19: 96. PMID: 28840470, DOI: 10.1007/s11886-017-0910-6.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsValvular heart diseaseHeart diseaseRisk of pregnancy-related complicationsManagement of valvular heart diseaseWomen of childbearing agePregnancy-related complicationsAcquired valvular heart diseaseRheumatic heart diseaseValvular abnormalitiesCongenital abnormalitiesCase reportSymptomatic diseaseChildbearing ageRegurgitant lesionsHemodynamic effectsPatient populationPregnancyPercutaneous interventionStenotic lesionsRefractory symptomsHigh riskObservational studyReviewThe numberDiseaseAbnormalities